Last reviewed · How we verify
NCT06600620: NOTE-AF
Intelligent Monitoring to Predict Atrial Fibrillation
trial testing Monitoring patients heart rythms with a wireless patch device in Atrial Fibrillation New Onset in 1,200 participants. Suspended.
31 July 2028
Quick facts
| Lead sponsor | Liverpool University Hospitals NHS Foundation Trust |
|---|---|
| Status | Suspended |
| Study type | OBSERVATIONAL |
| Enrollment | 1,200 |
| Start date | 23 September 2024 |
| Primary completion | 31 July 2028 |
| Estimated completion | 1 August 2028 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Monitoring patients heart rythms with a wireless patch device
Conditions studied
- Atrial Fibrillation New Onset — all drugs for Atrial Fibrillation New Onset →
- Postoperative Cardiovascular Complications — all drugs for Postoperative Cardiovascular Complications →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Liverpool University Hospitals NHS Foundation Trust
Who can join
50 and older, any sex, with Atrial Fibrillation New Onset or Postoperative Cardiovascular Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Atrial Fibrillation (AF) is the commonest arrhythmia worldwide, affects 5% of people over the age of 65 and increases the risk of stroke and heart failure. The investigators aim to detect clinical and subclinical episodes of atrial fibrillation lasting \>30 seconds to develop risk prediction models to identify patients at high risk for ischaemic stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intelligent monitoring to predict atrial fibrillation (NOTE-AF): clinical study 1 for the 'Health virtual twins for the personalised management of stroke related to atrial fibrillation (TARGET)' project - a protocol for a prospective cohort analysis.
Essa H, Johnston B, Lip GYH, Ortega-Martorell S, et al · · 2026 · PMID 41485778 · DOI 10.1136/bmjopen-2025-099658
Verify or expand the search:
- PubMed search for NCT06600620
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation New Onset
Currently open trials in the same condition.
- NCT05841056 — Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial · Phase 3 · recruiting
- NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
- NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF · NA · recruiting
- NCT05444335 — Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years · NA · active not recruiting
- NCT05229211 — Tracking Atrial Fibrillation After Intensive Care Admission · recruiting
Other Liverpool University Hospitals NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07391553 — Achilles Tendon Rupture Patient Outcomes at 12 Months · not yet recruiting
- NCT07034469 — Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment · NA · not yet recruiting
- NCT06566638 — Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction o · NA · not yet recruiting
- NCT06271031 — Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infe · unknown
- NCT06037759 — Novel Cardiovascular Biomarkers in Patients With Kidney Disease · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06600620 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liverpool University Hospitals NHS Foundation Trust
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06600620.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing